Former Lilly Exec Daniels Wins Indiana Governorship
This article was originally published in The Pink Sheet Daily
Executive Summary
The brandname industry may have an opportunity to work with Indiana to achieve its oft-stated goal of making patient assistance programs more visible and successful. Daniels supports expanded use of discount programs, including the federal 340(B) program.
You may also be interested in...
PhRMA Promises “FastAccess” To Patient Assistance Programs
The Pharmaceutical Research & Manufacturers of America is creating a unified enrollment form to simplify access to industry patient assistance programs
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
Medicare Reaffirms Faith In Formulary Review Process Ahead Of Part D Changes
Dramatic transformation in the US Medicare Part D benefit design does not require any changes to CMS’ overall approach to reviewing formulary submissions from private drug plan sponsors, the agency says in its final guidance implementing the design changes for 2025.